Shanghai Raas Blood Products Co.,Ltd.’s Net Profit Rose 14.8% in First Three Quarters of 2022

Shanghai Raas Blood Products Co.,Ltd. (上海莱士血液制品股份有限公司) (002252.SZ) reported a net profit of 1.6 billion yuan in the first three quarters of 2022, up 14.8% year-on-year.

Meanwhile, the company posted 5 billion yuan in revenue, up 62.5% year-on-year.

At the end of the reporting period, it had 30.2 billion yuan in total assets and 1.4 billion yuan in total liabilities, with a liability-to-asset ratio of 4.8%.